Journal of the American College of Nutrition, Vol 9, Issue 2 114-119, Copyright © 1990 by American College of Nutrition

JOURNAL ARTICLE

Effect of intravenous epinephrine on serum magnesium and free intracellular red blood cell magnesium concentrations measured by nuclear magnetic resonance

E. Ryzen, K. L. Servis and R. K. Rude
Department of Internal Medicine, University of Southern California, Los Angeles.

Hypomagnesemia is a common clinical finding in hospitalized patients and can cause hypocalcemia, cardiac arrhythmias, muscular weakness, and hypokalemia. Hypomagnesemia usually implies cellular magnesium (Mg) depletion, but stress and some clinical conditions which raise serum catecholamine concentrations may lower serum Mg (sMg) concentrations. To help investigate the mechanism and degree of the effect of catecholamines on sMg concentration, we gave intravenous epinephrine (0.1 microgram/kg/min) to 12 normal volunteers for 2 hours. The sMg concentration fell from 1.86 +/- 0.04 mg/dl to 1.63 +/- 0.05 mg/dl (mean +/- SEM, p less than 0.01). Pre-infusion intracellular free Mg (Mg++) in red blood cells (RBC) as measured by nuclear magnetic resonance spectrophotometry (NMR) was 171 +/- 7.6 microM and did not differ significantly from post-infusion RBC Mg++, 186 +/- 12.6 microM. Total blood mononuclear cell Mg content and urine Mg excretion also did not change. These data suggest that epinephrine has a small but significant effect on the lowering of sMg concentrations. Endogenous catecholamine release during stress or acute illness may therefore contribute to the hypomagnesemia seen in acutely ill patients. Our data also suggest that hypomagnesemia seen under conditions of acute stress may not always imply depleted tissue Mg stores. As no absolute change in cellular Mg or in urinary Mg excretion was demonstrated, acute intracellular shifts of Mg into blood cells and/or urinary Mg losses may not account for the hypomagnesemia. The prevalence and clinical consequences of stress hypomagnesemia require further investigation.

This article has been cited by other articles:

				A. W. C. Kung Thyrotoxic Periodic Paralysis: A Diagnostic Challenge J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2490 - 2495. [Abstract] [Full Text] [PDF]

				M. A. Manoukian, J. A. Foote, and L. M. Crapo Clinical and Metabolic Features of Thyrotoxic Periodic Paralysis in 24 Episodes Arch Intern Med, March 22, 1999; 159(6): 601 - 606. [Abstract] [Full Text] [PDF]

				D. Keenan, A. Romani, and A. Scarpa Differential Regulation of Circulating Mg2+ in the Rat by ß1- and ß2-Adrenergic Receptor Stimulation Circ. Res., November 1, 1995; 77(5): 973 - 983. [Abstract] [Full Text]